3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
8
Leukemia, Myeloid, Chronic-Phase
7
Leukemia
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Thrombocythemia, Essential
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Thrombosis
1
Primary Myelofibrosis
1
Polycythemia
1
Pharyngeal Neoplasms
1
Paranasal Sinus Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Laryngeal Neoplasms
1
Glioblastoma
1
Congenital Abnormalities
1
Brain Neoplasms
1
Astrocytoma
1
Anemia, Refractory, with Excess of Blasts
1
Adenocarcinoma
1
Interventions
Injections
2
enoxaparin sodium
1
bemiparin
1
apixaban
1
Phlebotomy
1
Hydroxyurea
1
Heparin
1
Dalteparin
1
Clopidogrel
1
Aspirin
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Thrombosis
×
Hydroxyurea
×
Clear all
NCT01645124
2012-07-20
CYTO-PV
Consorzio Mario Negri Sud
Phase 3
Terminated
365 enrolled